In preclinical models, liver fat and liver enzymes were both reduced by LY3437943 and by HM15211
GLP-1 medications slow gastric emptying (the rate at which food moves through the digestive tract) and promote satiety
At the end of the study, improved protein, enzyme, and bilirubin levels were measured and glutathione was deemed to have a potential therapeutic effect for those with fatty liver diseases
Targeting mitochondria with avocatin B induces selective leukemia cell death
-- Side Effect Monitoring -- Track nausea, fatigue, dizziness, and other common side effects with intensity levels
GLP-1 Safety: Known Risks and Rare Complications While GLP-1 medications are clinically proven to be safe, they carry specific risks that require professional oversight